Page last updated: 2024-10-25
debrisoquin and Balkan Endemic Nephropathy
debrisoquin has been researched along with Balkan Endemic Nephropathy in 2 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Mantle, PG | 1 |
Amirtharajah, M | 1 |
Klippel, S | 1 |
Miljkovic, A | 1 |
Naik, JT | 1 |
Nestler, S | 1 |
Nikolov, IG | 1 |
Chernozemsky, IN | 1 |
Idle, JR | 1 |
Other Studies
2 other studies available for debrisoquin and Balkan Endemic Nephropathy
Article | Year |
---|---|
Debrisoquine 4-hydroxylation and the Balkan endemic nephropathy.
Topics: Animals; Balkan Nephropathy; Crosses, Genetic; Debrisoquin; Diet; Disease Models, Animal; Female; Fo | 1999 |
Genetic predisposition to Balkan endemic nephropathy: ability to hydroxylate debrisoquine as a host risk factor.
Topics: Adult; Aged; Balkan Nephropathy; Bulgaria; Carcinoma, Transitional Cell; Case-Control Studies; Cytoc | 1991 |